JMP Securities maintained a positive outlook on Kalvista Pharmaceuticals Inc (NASDAQ:KALV), reiterating a Market Outperform ...

JMP Securities initiated coverage on Astria Therapeutics (NASDAQ: ATXS), assigning a Market Outperform rating and setting a ...

Pharvaris (PHVS) is climbing 3% after investment bank JMP Securities raised its price target on the shares to $55, based on ...

JMP Securities analyst Jason Butler lowered the firm’s price target on Ironwood (IRWD) to $14 from $23 and keeps an Outperform rating on the ...

JMP Securities analyst Devin Ryan raised the firm’s price target on Raymond James (RJF) to $190 from $175 and keeps an Outperform rating on the ...

JMP Securities raised the price targets on Cloudflare (NET) and CyberArk Software (CYBR), while highlighting an industry ...

This article focuses on the latest stock ratings and analyst calls on AI companies involved in digital advertising, drone ...

Truist also published new coverage on Cloudflare today, maintaining a buy rating on the stock and raising its one-year price target from $120 per share to $140 per share. Notably, today's gains pushed ...

JMP Securities analyst Constantine Davides raised the firm’s price target on Option Care Health (OPCH) to $35 from $30 and ...

Covering some solid dividend stocks for JMP, analyst Aaron Hecht sees a reason to bet on higher value in the coming year. He notes that multiple tailwinds are coming together, and will likely lead ...